Literature DB >> 2548394

New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase.

D Barrett1, N A Breslau, M B Wax, P B Molinoff, R W Downs.   

Abstract

Patients with pseudohypoparathyroidism type Ia have resistance to multiple hormones because of deficient activity of the stimulatory guanine nucleotide-binding protein (Gs) that couples membrane receptors to activation of adenylate cyclase. However, in a subset of patients with pseudohypoparathyroidism who have resistance to multiple hormones yet possess normal erythrocyte membrane Gs activity, the biochemical abnormality responsible for hormone resistance has remained undefined. Cultured skin fibroblasts were derived from a patient with this atypical form of pseudohypoparathyroidism. In the patient's fibroblast membranes, adenylate cyclase stimulation mediated by Gs after fluoride ion treatment produced only 52% of normal activity, yet fibroblast membrane Gs activity measured by cyc- complementation was normal. Activation of the catalytic unit of adenylate cyclase with manganese produced 49% of normal activity; manganese plus forskolin produced 54% of normal adenylate cyclase activity. beta-Adrenergic receptor coupling to Gs and phosphodiesterase activity were normal. A defect in the catalytic unit of adenylate cyclase can account for these results and may be a mechanism for clinical resistance to multiple hormones that act through adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548394     DOI: 10.1152/ajpendo.1989.257.2.E277

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

Review 3.  Abnormalities in G protein-coupled signal transduction pathways in human disease.

Authors:  A M Spiegel; L S Weinstein; A Shenker
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

4.  Endocrine and molecular biological studies in a German family with Albright hereditary osteodystrophy.

Authors:  V Schuster; T Eschenhagen; K Kruse; P Gierschik; H W Kreth
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

5.  Mosaicism for GNAS methylation defects associated with pseudohypoparathyroidism type 1B arose in early post-zygotic phases.

Authors:  Francesca Marta Elli; Paolo Bordogna; Maura Arosio; Anna Spada; Giovanna Mantovani
Journal:  Clin Epigenetics       Date:  2018-02-06       Impact factor: 6.551

6.  Identification of a novel mutation in pseudohypoparathyroidism type Ia in a Chinese family: A case report.

Authors:  Yuchen Tang; Fenping Zheng; Xihua Lin; Qianqian Pan; Lin Li; Hong Li
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.